McKesson stock faces earnings test with profit growth in focus
Published on 11/01/2026 at 17:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMcKesson earnings set the weekly agenda
- McKesson is expected to report fiscal second-quarter 2027 results on Wednesday, November 4, after the market close.
- Analysts expect earnings of 10.72 US dollars per share and revenue of 109.90 billion US dollars.
- The report will show whether McKesson can extend its recent record of earnings beats.
McKesson stock faces its next major catalyst on Wednesday, November 4, 2026, when the company is expected to release fiscal second-quarter results after the market close. The earnings call is scheduled for 4:30 p.m. Eastern Time, according to MarketBeat.
Estimates point to continued growth
Analysts expect McKesson to post earnings of 10.72 US dollars per share on revenue of 109.90 billion US dollars. That compares with 9.86 US dollars per share and 103.15 billion US dollars of revenue in the year-earlier quarter, implying expected growth of 8.7 percent in earnings and 6.5 percent in revenue.
The release will give investors a fresh read on demand across McKesson's pharmaceutical distribution, specialty-care and medical-surgical operations. The central question is whether the company can convert revenue growth into profit while maintaining its full-year outlook.
Recent results raise the bar
McKesson last reported on August 5, 2026, with fiscal first-quarter earnings of 9.93 US dollars per share and revenue of 105.38 billion US dollars. MarketBeat says the company has exceeded consensus earnings estimates in six of its last eight quarters, raising the importance of the next forecast and any management comments on the full year.
McKesson stock traded at 891.20 euros on Lang & Schwarz at 17:06 CET on Sunday, November 1, 2026.
real-time quote of McKesson stock provides the latest trading view for investors ahead of the announcement.
McKesson Corporation
- ISIN: US58155Q1031
- Ticker: MCK
- Upcoming event: Fiscal second-quarter 2027 results expected Wednesday, November 4, 2026, after the market close
- Analyst EPS estimate: 10.72 US dollars
- Analyst revenue estimate: 109.90 billion US dollars
- Lang & Schwarz quote: 891.20 euros on Sunday, November 1, 2026, at 17:06 CET
Broader sentiment in the S&P 500 may shape the market backdrop for US healthcare shares during the week.
